http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009098860-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_948c57b2430d2713f72a0c5992c30918 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9adfd8615849e9c22cdc691df7f8b6ed |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06Q50-22 |
| filingDate | 2007-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19ba2031d876d2f110e6be37a4be7d06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06ee8f4ede8fc91aa6ca190f81777710 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99e7a3d7122d3d246e2e6c28c663ebbe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8403e4f83b1c3ede380cff14684c11e1 |
| publicationDate | 2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009098860-A |
| titleOfInvention | Clinical trial data effect estimation device |
| abstract | [Problem] When estimating the effects of drugs, foods for specified health use, etc., the clinical trial data of healthy subjects affects the entire clinical trial, and the clinical trial data of mildly ill patients affect the entire clinical trial There is provided a clinical trial data effect estimation device capable of estimating a boundary point with a region and appropriately estimating an effect of a taken drug or the like even if the clinical trial data is small. An arithmetic processing unit for processing clinical trial data including data on healthy subjects, a clinical trial data file for recording treatment conditions, pre-treatment values, and post-treatment values of the clinical trial data, and a program file for recording a calculation program and the like. A clinical trial data effect estimation device having a data storage unit, wherein the calculation processing unit sets an inflection point candidate value setting means obtained by setting a data processing range and a step size based on the pre-treatment value, and the calculation Inflection point determination means for determining an optimal inflection point from the result obtained by substituting the inflection point candidate value and the clinical trial data into the first model expression of the program is provided. [Selection] Figure 2 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011070441-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014519076-A |
| priorityDate | 2007-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555697 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123908 |
Total number of triples: 18.